Targeting of the Antivascular Drug Combr
Targeting of the Antivascular Drug Combretastatin to Irradiated Tumors Results in Tumor Growth Delay
โ
Christopher B. Pattillo; Farid Sari-Sarraf; Ramakrishna Nallamothu; Bob M. Moore
๐
Article
๐
2005
๐
Springer US
๐
English
โ 256 KB